Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06273917 · ClinicalTrials.gov registry record · NA
Deprescribing Potentially Inappropriate Medications in the Emergency Department for Persons Living With Dementia
A NA study, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT06273917 is a NA study that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 300 participants.
The verdict
NCT06273917, a NA study, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
Aim 1: To demonstrate the feasibility by determining proportion of completed medication reconciliation, Central Nervous System active Potentially Inappropriate Medication (CNS PIM) use among patients with Alzheimer's Disease and Related Dementias (ADRD) and Mild Cognitive Impairment (MCI) in the emergency department (ED), and communication between ED clinical pharmacists and outpatient prescribers. Aim 2: To demonstrate the feasibility of collecting the primary and secondary outcomes for a subsequent study. The future primary outcome will be reduction in CNS PIMs 90 days after an ED visit. Secondary outcomes will include outpatient follow-up, repeat ED visits, and hospitalizations during the 90 days following an ED visit. Aim 3: To demonstrate the acceptability of the PRIDE intervention to outpatient clinicians using the Acceptability of Intervention Measure and qualitative analysis of responses.
Interventions
- OTHER PRIDE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-07-09 |
| Est. Completion | 2025-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06273917
The ClinicalTrials.gov registry entry for NCT06273917 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PRIDE is the first listed.
NCT06273917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06273917 about?
NCT06273917 is a clinical study titled "Deprescribing Potentially Inappropriate Medications in the Emergency Department for Persons Living With Dementia". Aim 1: To demonstrate the feasibility by determining proportion of completed medication reconciliation, Central Nervous System active Potentially Inappropriate Medication (CNS PIM) use among patients with Alzheimer's Disease and Related Dementias (ADRD) and Mild Cognitive Impairment (MCI) in the eme...
What is the current status of trial NCT06273917?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2024-07-09. Estimated completion is 2025-10-31.
What interventions are being tested in trial NCT06273917?
The interventions under investigation include: PRIDE (OTHER).
Who is sponsoring clinical trial NCT06273917?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.